Analytical Data
-
基因名
PCYT1b
- Application
-
别名
CTB; CCTB; CCT-beta; Phosphorylcholine transferase B; CTP:phosphocholine cytidylyltransferase B
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q811Q9
-
表达区间
His62~Thr295
-
分子量
27&31kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PCYT1b, a key enzyme in the biosynthesis of phosphatidylcholine, has garnered significant interest in the field of lipid metabolism due to its crucial role in membrane integrity and cell signaling. Phosphatidylcholine is the most abundant phospholipid in cellular membranes, and its synthesis is vital for maintaining cellular structure and function. The enzyme PCYT1b catalyzes the conversion of cytidine diphosphate-diacylglycerol to phosphatidylcholine, highlighting its importance in lipid homeostasis. Recent studies have suggested that dysregulation of PCYT1b may be linked to various metabolic disorders, including obesity and cardiovascular diseases. Furthermore, understanding the mechanisms by which PCYT1b operates can provide insights into potential therapeutic targets. Recombining PCYT1b has enabled researchers to explore its biochemical properties, functional mechanisms, and interactions with other proteins and lipids in greater detail. This research not only aids in elucidating the enzyme's role in cellular metabolism but also opens avenues for developing lipid-related treatments. The recombinant form of the protein allows for more straightforward studies of its activity and regulation, paving the way for potential applications in biotechnology and medicine. Overall, the investigation into PCYT1b and its enzymatic pathways has significant implications for understanding lipid-related diseases and enhancing therapeutic strategies.
